Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SNRS- Sunrise Technologies -- Ignore unavailable to you. Want to Upgrade?

To: sandbag who wrote (1382)	7/28/1998 9:02:00 AM
From: Double E	Read Replies (1) \| Respond to of 4140

I've been trying to think of what type of news and PR Sunrise can release between now and when they make their final submission and receive their final approval. They MUST walk a very fine line or they will run into problems with FDA . . . and they DO NOT want to do that. I never would have guessed something like this but that is what Omnicom is all about. This release may seem simple to some or even insignificant to others but make no mistake, I agree with CUBBY and sandbag, this is GOOD NEWS. It may not generate new interest in the stock but it should sure help to steady some weak and wavering hands. SNRS will take every opportunity in the months ahead to put forward their results so far and emphasize the safety profile. If Sunrise is making this kind of comparison to PRK and LASIK right now, imagine where they will go when they have an FDA approved product and process! Let's hope they continue to find creative ways to walk the fine line for the next 12 months or so. The awareness of this safer alternative to PRK and LASIK for hyperopia is the key to what we, as investors, are all in this stock for. Have a great day! Double E